Related Experiment Video

Updated: Jun 8, 2026

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

Antithrombotic therapy in patients with diabetes mellitus and coronary artery disease

José Luis Ferreiro1, Ángel R Cequier, Dominick J Angiolillo

  • 1IDIBELL-Hospital Universitari de Bellvitge, Department of Cardiology, Interventional Cardiology Unit, L'Hospitalet de Llobregat, Barcelona, Spain.

Diabetes & Vascular Disease Research
|October 6, 2010
PubMed

Insights

Patients with diabetes mellitus (DM) experience poor outcomes despite antiplatelet therapy due to low drug response. New strategies are needed to improve cardiovascular event reduction in these high-risk individuals.

Area of Science:

  • Cardiology
  • Pharmacology
  • Diabetology

Background:

  • Coronary artery disease (CAD) patients benefit from antiplatelet therapy.
  • Diabetes mellitus (DM) patients with CAD face worse outcomes and higher cardiovascular event rates.
  • Low response to standard oral antiplatelet agents is prevalent in DM patients, contributing to poor outcomes.

Purpose of the Study:

  • To review current antiplatelet agents for DM patients.
  • To analyze the benefits and limitations of existing therapies in DM.
  • To explore novel antithrombotic agents and strategies for high-risk DM patients.

Main Methods:

  • Literature review of antiplatelet therapies.
  • Analysis of treatment efficacy and limitations in diabetic patients.
  • Evaluation of emerging antithrombotic approaches.

Main Results:

  • Current antiplatelet strategies show limitations in DM patients.
  • Suboptimal response to standard therapies is a key issue.
  • Newer agents and strategies show promise for improved outcomes.

Conclusions:

  • DM significantly worsens cardiovascular outcomes despite standard antiplatelet treatment.
  • Enhanced antiplatelet strategies are crucial for managing high-risk DM patients.
  • Ongoing research into novel antithrombotics is essential to overcome current therapeutic challenges.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...